Medicenna Therapeutics Corp (MDNAF)
OTCMKTS: MDNAF · Delayed Price · USD
1.420
-0.010 (-0.70%)
Jul 23, 2024, 4:00 PM EDT - Market closed
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of $106.19 million as of July 24, 2024. Its market cap has increased by 129.84% in one year.
Market Cap
106.19M
Enterprise Value
76.57M
1-Year Change
129.84%
Ranking
n/a
Category
Stock Price
$1.42
Market Cap Chart
Since August 24, 2020, Medicenna Therapeutics's market cap has decreased from $225.00M to $106.19M, a decrease of -52.81%. That is a compound annual growth rate of -20.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 1, 2023 | 10.90M | -65.83% |
Dec 30, 2022 | 31.90M | -63.67% |
Dec 31, 2021 | 87.80M | -61.66% |
Dec 31, 2020 | 229.00M | 1.78% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 814.94B |
Novo Nordisk | 579.91B |
UnitedHealth Group | 520.32B |
Johnson & Johnson | 372.29B |
Merck & Co. | 318.55B |
AbbVie | 304.29B |
AstraZeneca | 244.04B |
Novartis AG | 207.64B |